| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 26, 2025 | PAHC Phibro Animal Health Corp | Bendheim Jack49 | President And CEO | Sell | 12,320 | $43.97 | $541,673.79 | -14.4% | +18.9% | - | |
| Nov 26, 2025 | ORGO Organogenesis Holdings Inc. | Nussdorf Glenn H70 | Director, 10% Owner | Sell | 300,000 | $5.31 | $1,592,120.43 | -3.3% | -25.6% | - | |
| Nov 25, 2025 | LLY Eli Lilly & Co | Lilly Endowment Inc | - | Sell | 147,061 | $1,095.35 | $161,082,639.62 | - | -4.6% | - | |
| Nov 25, 2025 | LLY Eli Lilly & Co | Lilly Endowment Inc | - | Sell | 15,632 | $1,109.30 | $17,340,624.51 | - | -4.6% | - | |
| Nov 25, 2025 | NBIX Neurocrine Biosciences Inc | Morrow George J71 | Director | Sell | 15,000 | $143.37 | $2,150,512.50 | -68.0% | -10.5% | - | |
| Nov 25, 2025 | BHC Bausch Health Companies Inc. | Paulson & Co. Inc.72 | 10% Owner | Buy | 2,500,000 | $6.25 | $15,625,000.00 | +3.5% | -5.4% | - | |
| Nov 25, 2025 | PLNH Planet 13 Holdings Inc. | Wren Chris | VP Of Operations | Sell | 61,600 | $0.19 | $11,784.08 | -1.3% | - | - | |
| Nov 25, 2025 | PBH Prestige Consumer Healthcare Inc. | Byom John E | Director | Sell | 3,000 | $59.35 | $178,050.00 | -5.5% | +18.1% | - | |
| Nov 25, 2025 | AMPH Amphastar Pharmaceuticals, Inc. | Prins Richard K61 | Director | Sell | 4,179 | $27.10 | $113,253.41 | -10.6% | -0.5% | - | |
| Nov 25, 2025 | UTHR United Therapeutics Corp | Rothblatt Martine A | Chairperson &CEO | Sell | 8,000 | $473.05 | $3,784,418.79 | -61.9% | -2.4% | - | |
| Nov 24, 2025 | LLY Eli Lilly & Co | Lilly Endowment Inc | - | Sell | 142,307 | $1,068.52 | $152,058,090.84 | - | -1.1% | - | |
| Nov 24, 2025 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 2,631 | $35.22 | $92,663.82 | -1.7% | -58.9% | - | |
| Nov 24, 2025 | UTHR United Therapeutics Corp | Edgemond James | CFO And Treasurer | Sell | 21,000 | $473.64 | $9,946,543.52 | -7.9% | -0.6% | - | |
| Nov 24, 2025 | UTHR United Therapeutics Corp | Benkowitz Michael | President And COO | Sell | 22,500 | $473.66 | $10,657,280.25 | -100% | -0.6% | - | |
| Nov 24, 2025 | TSNDF Terrascend Corp. | Schutter Edward J | Director | Sell | 546,174 | $0.43 | $233,848.09 | -9.5% | - | - | |
| Nov 24, 2025 | JNJ Johnson & Johnson | Johnson & Johnson59 | 10% Owner | Sell | 2,700 | $10.05 | $27,132.00 | - | +19.3% | - | |
| Nov 24, 2025 | PLNH Planet 13 Holdings Inc. | Wren Chris | VP Of Operations | Sell | 338,900 | $0.17 | $57,610.41 | -1.8% | - | - | |
| Nov 21, 2025 | LLY Eli Lilly & Co | Lilly Endowment Inc | - | Sell | 105,326 | $1,058.66 | $111,504,097.67 | - | -3.4% | - | |
| Nov 21, 2025 | UTHR United Therapeutics Corp | Rothblatt Martine A | Chairperson &CEO | Sell | 8,000 | $476.51 | $3,812,082.20 | -52.8% | +1.2% | - | |
| Nov 20, 2025 | LLY Eli Lilly & Co | Lilly Endowment Inc | - | Sell | 37,148 | $1,051.66 | $39,067,116.63 | - | -2.2% | - | |
| Nov 20, 2025 | PAHC Phibro Animal Health Corp | Bendheim Jack49 | President And CEO | Sell | 3,520 | $41.76 | $147,001.69 | -3.7% | +25.2% | - | |
| Nov 20, 2025 | TEVA Teva Pharmaceutical Industries Ltd | Fox Christine | EVP, Head Of U.s. Commercial | Sell | 28,229 | $24.78 | $699,523.09 | -30.7% | +40.5% | - | |
| Nov 19, 2025 | LLY Eli Lilly & Co | Lilly Endowment Inc | - | Sell | 167,526 | $1,051.17 | $176,098,702.11 | - | -1.3% | - | |
| Nov 19, 2025 | UTHR United Therapeutics Corp | Rothblatt Martine A | Chairperson &CEO | Sell | 8,000 | $473.67 | $3,789,373.05 | -54.6% | +1.2% | - | |
| Nov 18, 2025 | RMTI Rockwell Medical, Inc. | Cooper John G | Director | Sell | 5,079 | $0.87 | $4,418.73 | -3.5% | +17.7% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.